Atara biotherapeutics to present at the 42nd annual j.p. morgan healthcare conference

Thousand oaks, calif.--(business wire)---- $atra #cart--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic epstein-barr virus (ebv) t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that pascal touchon, president and chief executive officer, will present at the 42nd annual j.p. morgan healthcare conference on thursday, january 11, at 9:45 a.m. pst / 12:45 p.m. est in san francisco, cal.
ATRA Ratings Summary
ATRA Quant Ranking